In light of these observations, it is possible that the CXCR3 KO donor TILs stemmed from the minority population that did not successfully ablate CXCR3 expression, but downregulated CXCR3 expression after reaching the tumor sites. This evidence concerns the gene CXCR3 and neoplasm.